# Future Work Roadmap

## Overview

Planned enhancements and future directions for the CardioRetina-AI project.

## Phase 1: Immediate Improvements (Next 3 Months)

### Documentation
- [ ] Add video tutorials for setup and usage
- [ ] Create interactive Jupyter notebooks
- [ ] Expand troubleshooting guide with more examples
- [ ] Add architecture decision records (ADRs)

### Code Quality
- [ ] Increase test coverage to 90%+
- [ ] Add integration tests for full pipeline
- [ ] Implement property-based testing
- [ ] Add performance benchmarks

### Features
- [ ] Batch inference API endpoint
- [ ] Model versioning and A/B testing support
- [ ] Real-time inference monitoring dashboard
- [ ] Export to TensorRT for faster inference

## Phase 2: Research Extensions (3-6 Months)

### Model Improvements
- [ ] **Attention-based fusion**: Replace concatenation with cross-modal attention
- [ ] **Larger ViT models**: Experiment with ViT-Large for better global features
- [ ] **Multi-scale analysis**: Process multiple image resolutions
- [ ] **Self-supervised pretraining**: Use retinal-specific pretraining

### Data Enhancements
- [ ] **Longitudinal analysis**: Track changes over time
- [ ] **Multi-image fusion**: Combine left and right eye images
- [ ] **Additional modalities**: Incorporate OCT if available
- [ ] **Synthetic data**: Generate synthetic retinal images for augmentation

### Explainability
- [ ] **Attention visualization**: Show ViT attention maps
- [ ] **Concept activation vectors**: Identify learned concepts
- [ ] **Uncertainty quantification**: Add confidence intervals
- [ ] **Counterfactual explanations**: Show what would change prediction

## Phase 3: Clinical Research (6-12 Months)

### Validation Studies
- [ ] **External validation**: Test on independent datasets
- [ ] **Multi-center study**: Collaborate with multiple hospitals
- [ ] **Prospective validation**: Test on new incoming data
- [ ] **Reader study**: Compare with ophthalmologist performance

### Fairness & Bias
- [ ] **Demographic analysis**: Evaluate across age, gender, ethnicity
- [ ] **Fairness interventions**: Implement bias mitigation techniques
- [ ] **Dataset diversity**: Collect more diverse training data
- [ ] **Subgroup analysis**: Detailed performance by population

### Clinical Integration
- [ ] **FHIR/HL7 support**: Integrate with EHR systems
- [ ] **DICOM compatibility**: Support medical imaging standards
- [ ] **Clinical workflow integration**: Design for clinical use
- [ ] **Regulatory pathway**: Prepare for FDA/CE marking

## Phase 4: Production Readiness (12+ Months)

### Scalability
- [ ] **Distributed training**: Multi-GPU and multi-node
- [ ] **Model distillation**: Train smaller, faster student model
- [ ] **Edge deployment**: Run on mobile/edge devices
- [ ] **Cloud deployment**: AWS/GCP/Azure templates

### Monitoring
- [ ] **Model drift detection**: Monitor prediction distribution changes
- [ ] **Data drift detection**: Monitor input distribution changes
- [ ] **Performance monitoring**: Track accuracy over time
- [ ] **Alerting system**: Notify when metrics degrade

### Security & Compliance
- [ ] **HIPAA compliance**: For US healthcare
- [ ] **GDPR compliance**: For EU users
- [ ] **Audit logging**: Track all predictions
- [ ] **Authentication**: Role-based access control

## Research Questions to Explore

### Technical Questions
1. How does performance scale with dataset size?
2. What is the minimum image quality required?
3. Can we predict specific CVD types, not just risk?
4. How do different fundus cameras affect performance?

### Clinical Questions
1. What is the optimal screening interval?
2. Which clinical features are most predictive?
3. How does this compare with traditional risk calculators?
4. What is the cost-effectiveness for population screening?

### Ethical Questions
1. How do we ensure equitable performance across populations?
2. What are appropriate use cases vs. misuse cases?
3. How should uncertainty be communicated to users?
4. What is the impact on healthcare disparities?

## Community Contributions Welcome

### Areas for Contribution

| Area | Description | Difficulty |
|------|-------------|------------|
| **Documentation** | Tutorials, translations | Easy |
| **Testing** | Unit tests, benchmarks | Easy |
| **Frontend** | Web UI improvements | Medium |
| **Models** | New architectures | Medium |
| **Deployment** | Cloud templates | Medium |
| **Research** | Validation studies | Hard |

### How to Contribute

1. **Check existing issues**: Look for "good first issue" labels
2. **Discuss first**: Open an issue to discuss major changes
3. **Follow style**: Match existing code style and documentation
4. **Add tests**: Include tests for new features
5. **Update docs**: Document changes in relevant guides

## Decision Log

### Completed Decisions

| Date | Decision | Rationale |
|------|----------|-----------|
| 2024-01 | Hybrid CNN+ViT | Better than single models (ablation validated) |
| 2024-01 | Late fusion | Preserves modality-specific features |
| 2024-01 | FastAPI | Async support, auto-docs, performance |

### Pending Decisions

| Question | Options | Status |
|----------|---------|--------|
| Attention fusion? | Yes/No | Research phase |
| Multi-task learning? | CVD + diabetes + hypertension | Under consideration |
| Self-supervised pretraining? | SimCLR, MAE, custom | Not started |
| ONNX export default? | Yes/No | Testing performance |

## Resource Requirements

### Computational
- Phase 1: Current resources sufficient
- Phase 2: Multi-GPU training beneficial
- Phase 3: Cloud compute for large-scale validation
- Phase 4: Production infrastructure

### Data
- Phase 1: Current dataset sufficient
- Phase 2: 10K+ diverse images needed
- Phase 3: 100K+ multi-center data needed
- Phase 4: Continuous data collection

### Human Resources
- Phase 1: Individual contributor
- Phase 2: Small team (2-3 people)
- Phase 3: Multi-disciplinary team (5-7 people)
- Phase 4: Full product team (10+ people)

## Success Metrics

### Phase 1 Success
- Test coverage > 90%
- Documentation completeness score > 8/10
- Setup time < 30 minutes for new users

### Phase 2 Success
- AUC-ROC > 0.90 on external validation
- Inference time < 50ms (GPU)
- Model size < 50MB (distilled)

### Phase 3 Success
- FDA Q-Submission feedback
- Multi-center validation completed
- Clinical workflow pilot successful

### Phase 4 Success
- Deployed in 5+ clinical sites
- 1000+ daily predictions
- Zero critical security incidents

## Timeline Visualization

```
2024 Q1     Q2      Q3      Q4      2025 Q1     Q2
  |--------|-------|-------|--------|----------|
  [Phase 1: Foundation]
          [Phase 2: Research Extensions]
                  [Phase 3: Clinical Research]
                          [Phase 4: Production]
```

---

*Roadmaps are living documents. Priorities may shift based on research findings, community feedback, and resource availability.*
